@blackwellbooks.bsky.social please start posting

Great to see our work on preventive cancer vaccines, including LungVax, featured in this issue! @oxfordcancer.bsky.social @sarahblagden.bsky.social @timmunologist.bsky.social

Join us for our DPhil in Cancer Science Open Day on Tuesday 2nd September at 12:30pm to find out how a DPhil can be the next step in your cancer research career development! Register via our Eventbrite link before 1st Sept⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk www.eventbrite.co.uk/e/university...

Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬

Amazing news for our Institute @kiroxford.bsky.social @ox.ac.uk 🎉🍾😀 ! Looking forward to working with our @manchester.ac.uk colleagues to understand better how envrionmental determinants drive chronic inflammatory diseases !

Targeting monocyte dynamics in MS? In Immunotherapy Advances, Bibi et al. explore how shifting monocytes from inflammatory to reparative states may reshape MS treatment strategies. 📘 https://bit.ly/3EXOfaV ##MS #Monocytes #Neuroinflammation

New research by Rui Zhao et al. shows that high anti-drug antibody (ADA) levels after 3 cycles of camrelizumab are linked to shorter survival in patients with advanced solid cancers. 📉 Higher ADA = lower drug levels = worse outcomes. 🔗 https://bit.ly/461mc5B ##Immunotherapy #CancerResearch

🧬 Better understanding of immune rejection and evasion is setting the stage for next-gen therapies. Elizabeth Simpson reviews how foundational immunology is reshaping transplant and cancer treatment. 📖 https://bit.ly/44N141N ##TransplantImmunology #Immunotherapy

🧩 Antigen presentation is complex - but imaging is bringing clarity. @doreenlau.bsky.social‬ & @timmunologist.bsky.social‬ review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity. 📖 https://bit.ly/3TkIasN ##CancerImmunology

A high-affinity TCRxCD3 bispecific (ImmTAC®) efficiently redirects T cells to kill PRAME+ tumor cells, even at low epitope density. Combination with anti-PD-1 restores activity in exhausted T cells. One of the most read articles in ITA: https://bit.ly/40o5kT8 ##immunology

Mechanistic modelling reveals that both antigen-dependent and independent factors shape CAR T-cell dynamics in month-one lymphoma patients. IL-7/IL-15 levels and lymphodepletion matter more than CAR T-cell phenotype. 📖 Read: https://bit.ly/3U6fDY6 ##Immunotherapy

Yesterday we finished with prize-giving and drinks in the garden🥂🌱! 🏆 Posters for Bas, Cindy & Charlotte📃; postdoc talk for Qian 👩‍🏫 & best embossing artwork for Group8 🧑‍🎨 Shoutout to Lisha for the Rhodes House tours, acknowledging its history, the good and the uncomfortable ⚖️. What a day! #CIOawayday

✨ Kicking off #CIOawayday with our senior PIs sharing the experiments that changed their careers 🧑‍🔬👩‍🔬🧫 A reminder that serendipity, curiosity, and pub chats can spark groundbreaking ideas 🤓 Clearly science thrives on kindness and collaboration and we got a lot of that in #CIO 😉🙃 #ScienceLife

🔬 Call for papers: We invite submissions for a special collection on Immunotherapies for Inborn Errors of Immunity. Explore genetics-guided, targeted treatments for primary immunodeficiency and immune dysregulation. 🗓️ Submit by Sept 2025 📖 Info: https://bit.ly/40o5kT8 ##Immunotherapy

#Bridge2ABetterFuture Challenge #10 complete with sueduncombe.bsky.social - the @cancerresearch.uk.org Big Hike (Cotswolds). 14 miles over the hills in the heatwave! Big steps bringing big discoveries Thanks for all donations fundraise.cancerresearchuk.org/page/bridge-... @oxfordcancer.bsky.social

Wonderful personal perspective from one of the founders of modern immunology

🚨 Last chance! Just a few days left to submit to our Special Collection: Imaging in Immunotherapy. Showcase your research in molecular imaging, immune monitoring, and image-guided drug delivery. Deadline: June 2025 🧬🖼️ #Immunotherapy #MolecularImaging 📩 Submit now: https://bit.ly/4j8c265

🚨 Researchers at over 120 UK institutions can publish open access for free in Immunotherapy Advances! No APC's, just impactful immunotherapy research shared with the world. 🌐 #OpenScience 🔗 Check eligibility here: bit.ly/4no9OTy

🫁 New study: M2 macrophages ease asthma symptoms in mice by boosting IL-10⁺ B-cell production via the TGF-β & oxidative phosphorylation pathways. 💡 Highlights the regulatory role of macrophage–B cell interactions in asthma. 🔗 Read more: https://bit.ly/4kXzogj

A big part of the CIO team will be at #BSI2025 🤓 especially now that our very own Max from the @ggillesp.bsky.social lab is featured on the conference poster! Looking forward to an exciting few days in Liverpool 🔬✨ #Immunology #CIOonTour

And we're off! Conference Co-Chair and @oncology.ox.ac.uk's Professor of Experimental Oncology @sarahblagden.bsky.social opens day two of the Cancer Prevention Research Conference in London.

Intramolecular Active displacement of common MHC I- peptide interactions drives peptide editing. Thanks for the call out Chris!

Really important to see the research generating a solid and powerful evidence base needed to help governments undo health inequalities

It’s under publicised that MANY universities and institutions around the world can publish in ITA for FREE under the read and publish deals with OUP. There are still inequalities - especially painful for BRIC who have great research infrastructure but no R&P deals yet. I hope this will change.

Review: From computational models of the splicing code to regulatory mechanisms and therapeutic implications https://www.nature.com/articles/s41576-024-00774-2 (read free: https://rdcu.be/dVNV4)

Great panel discussion chaired by our own @timmunologist.bsky.social on 'the role of immune dysfunction in cancer development and prevention' at today's Cancer Prevention Research Conference! @cancerresearchuk.org @americancancersoc.bsky.social

Immunology x cancer prevention = exciting research x healthy living

Feeling proud and looking sharp! Repping the Centre for Immuno-Oncology in style 😎 🔥Our top models, @anthonyhsieh.bsky.social and @mjwsim.bsky.social, rocking the CIO polos, in black and navy, which seems to be the unofficial Friday uniform around here! Team spirit (and outfits) on point 💛🖤💙

🔍 What do we really know about DC3s in solid tumors? This new article explores the phenotype, function & impact of DC3s across cancers - highlighting their complex roles in both immunity & immunosuppression. 📖 Read it now: https://bit.ly/3T2blRg ##Immunotherapy

Hi there @bsi-cipn.bsky.social - this is a great destination for your latest manuscript!

⏳ Last chance to submit! Our special collection on Imaging in Immunotherapy closes end of June 2025. Don’t miss the opportunity to feature your research on molecular imaging, drug delivery & immune monitoring. 📢 Submit now: https://bit.ly/4j8c265

🧪 New in Immunotherapy Advances: A scalable 3D in vitro model mimics CTL exhaustion, enabling deeper insight into T cell suppression and therapeutic response. Essential reading for anyone developing CTL-targeting immunotherapies. 🔗 https://bit.ly/4e1appC #Immunotherapy

Mighty oaks from acorns grow…..

🎙️ CIO Alert! Hot from the lab! 🔥 Dr. Lia Skolariki, a DPhil student in @eileenparkes.bsky.social group, shares the latest updates on her research in oesophageal cancer. Don't miss it! 🗓️ Today 🕐 13:00 📍 NDMRB Seminar Room 🔬🧬 #CIOSeminar #CancerResearch www.immonc.ox.ac.uk/team/aglaia-...

Multidisciplinary talent!

Congratulations Dr Sun!

A huge thanks to everyone who attended our OCION Symposium last week! Congratulations to our poster prize winner, Matthew Jackson, and runner up, Paul Tarlatt, from @oxcio.bsky.social!! Read all about the day on our website ⬇️ www.cancer.ox.ac.uk/news/action-...

Huge congratulations to our very own @drlennardlee.bsky.social for winning the UK Oncology Forum award for his work on #CancerVaccines! 🏆🎉 We’re proud to have you as part of #CIO!

@oncology.ox.ac.uk @medsci.ox.ac.uk @oxcio.bsky.social

Great day ahead!

The Deadly Six - Oxford's Battle with the Microbial World is a pop-up art exhibition on display now at the Museum. These six sculptures by Scottish artist Angela Palmer are woven from different species of willow and were created to mark the 30th anniversary of the Oxford Vaccine Group.

Join us for a panel discussion with experts from across healthcare and policy landscapes to explore how ethnicity is currently approached in genomic medicine and how it might be reimagined for the future. We hope to see you there!

Confluence of crises😩

Abstract Submission fast approaching - 11th July 2025

There are many! Itas legacy is safe.

Well this has got to be worth a repost! It has been a very rewarding two years and a major boost to UK cancer immunology👍🧫🧬🥼💉

Applications are open for the 2026 SCION Workshop. Connect with experienced faculty in the field and dedicated patient advocates. Learn more about clinical trial protocol development. Held Feb. 16–18, 2026 in Boston, MA. Apply by Aug. 7: www.sitcancer.org/career-devel...

@oxcio.bsky.social star.

Jet lagged and ready to rock #NK2025 in Tasmania